Comments
Abbott says kidney drug study halted; shares drop
19.10.2012. | (Reuters) - Abbott Laboratories Inc said its partner, Reata Pharmaceuticals, was discontinuing a late-stage trial of their potential blockbuster treatment for chronic kidney disease and diabetes based on safety concerns raised by an independent safety committee....
